Study of EO2002 for corneal swelling from endothelial damage
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vision loss mainly from central corneal swelling due to Fuchs dystrophy or post-cataract surgery problems.
- Your best corrected vision is between 20 and 65 letters on an eye chart (moderate to severe vision loss).
- Your central cornea is thicker than 600 micrometers, or it has recently thickened by at least 50 micrometers, or scans show swelling.
- You would normally be considered for a partial or full corneal transplant as standard care.
- You have no other serious eye diseases like active herpes infection, severe dry eye, or corneal scars, and you haven't had certain eye surgeries (e.g., glaucoma implants, refractive surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
This trial tests a new treatment for people with corneal swelling that needs surgery. It helps replace the inner layer of the cornea to improve vision.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
Hear when a new Corneal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.